Axe Capital Investments

Clear market notes built around the JSE, the rand, and what matters locally.

Axe Capital Trading News shares simple market takes on the stories moving South African shares, the rand, and a handful of major currency pairs.

Coverage focus:

1. JSE shares, South African companies, and the local knock-on effects of big market news.

2. The rand, interest rates, and a small group of forex pairs, with USD/ZAR at the centre.

3. Global stories only when they can actually change how a local investor might act.

Latest Finance Headlines

The Most Overlooked Reason Eli Lilly Stock Keeps Surging -- and It Has Nothing to Do With Weight Loss

2026-07-18 01:15 • The Motley Fool Positive Axe Cap view: Selective

While Eli Lilly's GLP-1 weight-loss drugs (Mounjaro and Zepbound) account for nearly two-thirds of revenues with strong growth, the company is strategically using profits from these drugs to build a diversified pipeline in immunology, oncology, and neuroscience through acquisitions like AtaiBeckley and Ventyx Biosciences. Non-weight-loss drugs are already showing 160% revenue growth, positioning Eli Lilly for long-term success beyond the limited patent life of GLP-1 drugs.

Axe note: Eli Lilly’s surge isn’t just about GLP-1 weight-loss drugs but smarter pipeline expansion—here’s why that matters for the rand and local markets.

Why StubHub Stock Plummeted by 13% This Week

2026-07-18 00:03 • The Motley Fool Negative Axe Cap view: Selective

StubHub stock fell 13% this week after Washington, D.C. passed the RESALE Act, capping secondary ticket resale markups at 10%. Analyst Jason Bazinet estimates that if similar caps averaging 15% are implemented across multiple jurisdictions currently considering such measures, StubHub's revenue could decline by 30% and EBITDA could drop by $95 million if 20% of sales are affected.

Axe note: Washington D.C.’s new law on ticket resale markups could cut StubHub’s revenue sharply, a warning for JSE stocks reliant on high-margin models.

Why Travelers Companies Stock Crushed the Market Today

2026-07-17 23:12 • The Motley Fool Positive Axe Cap view: Selective

Travelers Companies (TRV) surged 9.22% on Friday following a strong Q2 earnings report that significantly beat analyst expectations. Net income jumped 46% to $2.2 billion ($10.26 per share), crushing the consensus estimate of $5.34, driven by lower catastrophe losses, favorable reserve development, and higher investment income. However, revenue growth was modest at 1% year-over-year, and net written premiums declined slightly, suggesting the strong profitability may not be sustainable.

Axe note: Travelers Companies beat earnings expectations sharply but showed mixed signals beneath the headline numbers.

Browse the news layout →

Focus Areas

We keep the focus on JSE shares, the rand, and the currency moves that matter most to South African investors.

Market notes